Can Fite Biopharma ADR Representing 300 Ord Shs (CANF) stock is down -71.26% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CANF stock a score of 32 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 9. CANF's rank also includes a long-term technical score of 12. CANF has an Overall Score of 32. Find out what this means to you and get the rest of the rankings on CANF!